FSD Pharma Inc. submitted a Form 6-K to the SEC for March 2024, reporting its ongoing compliance and indicating that annual reports will be filed under Form 20-F. The filing was officially signed on March 27, 2024.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.